Recombinant Anti-IL23 x Anti-IL6 Bispecific Antibody (Diabody) (BSDB-178)

Recombinant Anti-IL23 x Anti-IL6 Bispecific Antibody (Diabody) is designed to be expressed as two polypeptide chains respectively. The two chains are cross-over pairing to form a dimer. It contains a His-tag for affinity purification. This BsAb can block two proinﬂammatory cytokines simultaneously. It is designed for the research of Inflammatory diseases therapy.

Datasheet INQUIRY

Specifications

Targets

IL23 & IL6

Type

Diabody

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Inflammatory diseases

Targets

Target 1

IL23

Gene ID

51561

UniProt ID

Q9NPF7

Alternative Names

P19; SGRF; IL-23; IL-23A; IL23P19; Interleukin-23; IL23; interleukin 23 subunit alpha

Target 2

IL6

Gene ID

3569

UniProt ID

P05231

Alternative Names

CDF; HGF; HSF; BSF2; IL-6; BSF-2; IFNB2; IFN-beta-2; interleukin 6; IL6

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-IL23 x Anti-IL6 Bispecific Antibody (Diabody) (BSDB-178). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-IL23 x Anti-IL6 Bispecific Antibody (Diabody) (CAT#: BSDB-178)

Specifications

Targets

Customer Reviews and Q&As